Negrini M, Rasio D, Hampton G M, Sabbioni S, Rattan S, Carter S L, Rosenberg A L, Schwartz G F, Shiloh Y, Cavenee W K
Jefferson Cancer Institute, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA.
Cancer Res. 1995 Jul 15;55(14):3003-7.
Chromosome 11 is frequently altered in several types of human neoplasms. In breast cancer, loss of heterozygosity has been described in two regions of this chromosome, 11p15 and 11q22-23. In this report we have dissected the two regions using high-density polymorphic markers, and have found that there are at least two independent areas of loss of heterozygosity in each region, suggesting that multiple genes on chromosome 11 may be targets of genetic alteration during tumor establishment or progression. The regions defined are: at 11p15, between loci D11S576 and D11S1318 and between D11S988 and D11S1318; at 11q23, between D11S2000 and D11S897 and between D11S528 and D11S990. The narrowing of these regions of loss should facilitate the cloning of the regions in yeast artificial chromosomes to identify the critical tumor suppressor genes.
11号染色体在几种人类肿瘤类型中经常发生改变。在乳腺癌中,该染色体的两个区域11p15和11q22 - 23出现了杂合性缺失。在本报告中,我们使用高密度多态性标记剖析了这两个区域,发现每个区域至少有两个独立的杂合性缺失区域,这表明11号染色体上的多个基因可能是肿瘤发生或进展过程中基因改变的靶点。所确定的区域为:在11p15上,位于基因座D11S576和D11S1318之间以及D11S988和D11S1318之间;在11q23上,位于D11S2000和D11S897之间以及D11S528和D11S990之间。这些缺失区域的缩小应有助于在酵母人工染色体中克隆这些区域,以鉴定关键的肿瘤抑制基因。